Literature DB >> 10781977

A continuing role for surgical bypass in the palliative treatment of pancreatic carcinoma.

A M Isla1, T Worthington, A K Kakkar, R C Williamson.   

Abstract

BACKGROUND: The use of palliative surgery for irresectable pancreatic cancer has been challenged by the advent of non-operative stenting, but it may still be appropriate for selected patients.
METHODS: Single-loop biliary and gastric bypass was carried out in 56 patients (mean age 60 years) with carcinomas of the pancreatic head that were irresectable because of vascular invasion or distant spread. In 42 patients without a preoperative tissue diagnosis, ductal carcinoma was confirmed by biopsy of the primary (n = 20) or secondary (n = 22) tumour. Preoperative biliary decompression in 31 patients led to positive bile cultures in 22 of 24 patients sampled.
RESULTS: There were no deaths in hospital or within 30 days. Complications in 20 patients (35%) included three biliary leaks, two of which required temporary percutaneous stents. The median postoperative hospital stay was 14 days. No re-operations were required before death, though 2 patients required percutaneous stenting of the biliary anastomosis for recurrent jaundice, 1 of whom had a radiation-induced stricture. The median survival was 6 (range 2-21) months.
CONCLUSION: Combined biliary and gastric bypass can be carried out with reasonable safety and remains a useful option for patients with potentially resectable tumours and an anticipated life expectancy of at least 6 months. Copyright 2000 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2000        PMID: 10781977     DOI: 10.1159/000018817

Source DB:  PubMed          Journal:  Dig Surg        ISSN: 0253-4886            Impact factor:   2.588


  10 in total

1.  Pancreatic cancer in sweden 1980-2000: a population-based study of hospitalized patients concerning time trends in curative surgery and other interventional therapies.

Authors:  Stefan Linder; Lennart Boström; Bo Nilsson
Journal:  J Gastrointest Surg       Date:  2006-05       Impact factor: 3.452

2.  Gastroduodenal stenting.

Authors:  Derrick F Martin; Hans-Ulrich Laasch
Journal:  Semin Intervent Radiol       Date:  2004-09       Impact factor: 1.513

3.  Surgical bypass vs. endoscopic stenting for pancreatic ductal adenocarcinoma.

Authors:  Edwina N Scott; Giuseppe Garcea; Helena Doucas; Will P Steward; Ashley R Dennison; David P Berry
Journal:  HPB (Oxford)       Date:  2009-03       Impact factor: 3.647

4.  Palliative surgical bypass for pancreatic and peri-ampullary cancers.

Authors:  Samrat Mukherjee; Hemant M Kocher; Robert R Hutchins; Satyajit Bhattacharya; Ajit T Abraham
Journal:  J Gastrointest Cancer       Date:  2007

5.  Preoperative staging and evaluation of resectability in pancreatic ductal adenocarcinoma.

Authors:  R Andersson; C E Vagianos; R C N Williamson
Journal:  HPB (Oxford)       Date:  2004       Impact factor: 3.647

Review 6.  Stent placement versus surgical palliation for adults with malignant gastric outlet obstruction.

Authors:  Emma Upchurch; Mark Ragusa; Roberto Cirocchi
Journal:  Cochrane Database Syst Rev       Date:  2018-05-30

7.  Surgical bypass and permanent iodine-125 seed implantation vs. surgical bypass for the treatment of pancreatic head cancer.

Authors:  Zhenjiang Zheng; Yinglong Xu; Shu Zhang; Guangchun Pu; Chi Cui
Journal:  Oncol Lett       Date:  2017-06-30       Impact factor: 2.967

Review 8.  Endoscopic retrograde cholangiopancreatography guided interventions in the management of pancreatic cancer.

Authors:  Muhammad Nadeem Yousaf; Hamid Ehsan; Ahsan Wahab; Ahmad Muneeb; Fizah S Chaudhary; Richard Williams; Christopher J Haas
Journal:  World J Gastrointest Endosc       Date:  2020-10-16

9.  Development and validation of a risk score for predicting clinical success after endobiliary stenting for malignant biliary obstruction.

Authors:  Nonthalee Pausawasdi; Panotpol Termsinsuk; Phunchai Charatcharoenwitthaya; Julajak Limsrivilai; Uayporn Kaosombatwattana
Journal:  PLoS One       Date:  2022-08-19       Impact factor: 3.752

10.  Development and validation of a 90-day mortality prediction model following endobiliary drainage in patients with unresectable malignant biliary obstruction.

Authors:  Panotpol Termsinsuk; Phunchai Charatcharoenwitthaya; Nonthalee Pausawasdi
Journal:  Front Oncol       Date:  2022-09-06       Impact factor: 5.738

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.